Eleven industry associations advocate for a separate medical devices law, criticizing the draft bill's pharma-style approach and calling for internationally aligned, risk-based regulation to boost innovation and safety.
The European Commission aims to tackle pricing barriers across member states, but industry experts caution that immediate savings for consumers are uncertain, citing possible unintended consequences such as decreased product variety and altered supply chains.